Articles

Orthopedic Intra-Articular Hyaluronic Acid (IAHA) Injection Market Size, Share, By Product Type (Low Molecular Weight HA, Medium Molecular Weight HA, and High Molecular Weight HA), Strength (2–5 mg/mL, 5–10 mg/mL, 10–20 mg/mL, and Others), Indications (Osteoarthritis (OA), Soft Tissue Injuries, Sports-Related Joint Injuries, and Others), Osteoarticular condition (Inflammatory, and Degenerative), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers (ASCs), and Others), and Region - Trends, Analysis, and Forecast till 2035
By Shweta Raskar | Business Development Specialist at Prophecy Market Insights As joint disorders such as osteoarthritis continue to affect millions globally, healthcare providers are turning to advanced treatments that reduce pain and improve mobility witho…

Discover why CPT coding accuracy is key from audits to automation and how outsourcing to 24 7 Medical Billing Services helps providers stay compliant
What is a CPT Code in Medical Billing? Ever noticed a five-digit number beside each item on your medical bill?That’s a CPT code, and it plays a crucial role in medical billing Services reimbursements. These codes are more than just numbers — they’re part of a structured language that healthcare providers, insurers, and patients use to communicate services clearly and accurately. Whether you’re a patient or a clinic owner, understanding CPT codes helps ensure transparent billing and faster claim approvals. Understanding CPT Codes CPT (Current Procedural Terminology) codes are five-digit numeric codes created by the American Medical…

Placental Tissues and Skin Substitutes Market Size, Share, By Product [Placental-Derived Allografts (Amniotic Membranes (Dehydrated, and Cryopreserved), Umbilical Cord-Derived Products, and Chorion-based Grafts), Skin Substitutes (Bioengineered skin (Cell-based and Acellular), Human-derived (Autografts, Allografts), and Synthetic and Composite Materials)], Application (Chronic & Acute Wound Management, Burns & Trauma, Surgical Reconstruction, Orthopedic & Sports Injuries, Dermatology and Plastic Surgery, and Others), End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035
Author: Shweta Raskar, Business Development Specialist at Prophecy Market Insights Prophecy Market Insights has released a detailed industr…

The intimate wash care products industry is projected to grow steadily through 2032, driven by changing hygiene standards, rising awareness, and evolving consumer preferences. Explore trends, market share insights, and growth drivers.
In recent years, the global health and wellness industry has seen an unprecedented evolution—not only in mainstream personal care but also in intimate hygiene. Among the most dynamic and increasingly visible segments is the intimate wash care products category, which has transitioned from niche awareness to everyday consumer routines in many parts of the world. As per data released by Acumen Research and Consulting, the global intimate wash care product market was valued at USD 28.6 billion in 2023 and is projected to reach USD 45.9 billion by 2032, expanding…

Examine the Regenerative Medicine Scaffolds Market growth—from USD 336.5 Million in 2023 to USD 1.72 Billion by 2032 at a 20.2% CAGR. Learn key trends, technology advances, regional dynamics, and tissue repair innovations reshaping healthcare.
Biomaterials engineered to restore, replace, or augment damaged tissues are gaining momentum—and at the core are Regenerative Medicine Scaffolds, critical in advancing tissue repair across orthopedics, neurology, wound healing, and cardiovascular applications. Our recent analysis at Acumen Research & Consulting sheds light on shifting market dynamics, emerging technologies, and region-wise growth projections. Market Size & Growth Outlook The Regenerative Medicine Scaffolds Market Size reached USD 336.5 million in 2023 and is forecast to so…

Explore the top companies by revenue in the breast biopsy devices market, segmented by tiers. Discover key trends, growth drivers, and market projections through 2033
The breast biopsy devices market is witnessing significant growth, propelled by the increasing global prevalence of breast cancer, advancements in diagnostic imaging technologies, and growing awareness of early cancer detection. As of 2025, the market is estimated to be worth $2.18 billion, and it is expected to reach $3.8 billion by 2033, growing at a CAGR of 6.3%. In this article, we highlight the top companies by revenue, explore key market segments, and examine the strategic trends shaping the future of breast cancer diagnostics. Request Sample Pages: https://www.regalintel…

Polyethylene glycol (PEG) is a versatile polymer widely employed in various industries, including pharmaceuticals, biotechnology, and materials science.
Its unique properties, such as biocompatibility, hydrophilicity, and flexible structure, make it an ideal candidate for myriad applications ranging from drug delivery systems to surface modification of biomaterials. PEG Synthesis has emerged as a critical approach to meet the specific needs of these diverse applications, enabling researchers and manufacturers to design PEG derivatives that offer enhanced performance and functionality.   Understanding PEG and Its Importance PEG is a polymer that consists of repeating units of ethylene glycol. It is available in various molecular weights, which directly influence its physical and ch…

BOC Sciences will present at ACS Fall 2025 (Booth #2230), one of the largest scientific conferences held by the American Chemical Society (ACS).
As the daunting challenges the world has been facing continue to bring an impact to the biopharmaceutical industry, this year's hybrid event, onsite in Washington, DC and virtually on 17-21 August, presents one more opportunity for BOC Sciences to demonstrate its world class capabilities for helping to make innovation in pharmaceuticals, biotech, and materials a reality.   Exhibition details: Event Date: August 17–21, 2025 Venue: Washington, DC & Virtual Exhibition Booth: #2230 Meeting Booking Channel: https://www.bocsci.com/events/boc-sciences-at-acs-fall-2025.html   At Booth #2230, BOC Sciences will spotlight its most adva…

Generic AI struggles with clinical accuracy, but domain-specific AI provides accurate, context-aware insights, significantly boosting pharma efficiency.
Unstructured clinical data (which doesn’t conform to structured fields like drop-downs or checkboxes) includes clinical notes, imaging reports, physician narratives, device data, and patient feedback and account for roughly 80% of US health records. These data provide a wealth of insights that can accelerate the development of effective drug therapies. Yet, we’re relying on people and generic AI to wade through the billions of clinical records created each year, 97% of which go unused. As drug developers rush to adopt AI, cracks in this approach are surfacing—from hallucinated findings (fabricated or inaccurate AI-generated content) to acro…

Health Studio offers a fully integrated, AI-powered platform to modernize clinical trials by solving key bottlenecks like slow recruitment and fragmented data. Built on Google Cloud, it centralizes the entire research lifecycle with digital onboarding, near real-time dashboards for remote participant monitoring via wearables, and seamless data integration with EHRs and REDCap. The platform's built-in AI provides predictive analytics to forecast dropout risk and detect adverse events, enabling researchers to run faster, smarter, and more adaptive trials while reducing costs and improving participant safety.
  AI-Powered Clinical Trials: A New Era of Research with Health Studio   Clinical trials are the backbone of medical advancement but they’ve historically been slow, costly…

Managing Director of Valneva Scotland, Greig Rooney, discusses the importance of equipping our leaders of tomorrow with the skills they need to succeed.
Scotland’s life sciences sector is smashing the targets set for it by the Industry Leadership Group, surpassing an £8bn contribution to the Scottish economy a full year ahead of schedule. With a new, ambitious target now set for 2035, the industry requires strategic action to solidify our position as a global leader in this high growth industry   This will not be easy in the face of difficult economic headwinds: stubborn inflation, expected rises in global oil and gas prices, higher cost of living for employees. Pair this with sectoral specific issues such as shortages of skilled labour, adequate infrastructure and funding, and the out…

For healthcare advertisers, the message is urgent: the digital transformation of pharmaceutical industry, and opportunities for advertisers, isn't a preview of the future it's happening now. The brands that thrive will be those that embrace platform diversity, cultivate authentic HCP relationships, orchestrate sophisticated congress strategies and integrate AI thoughtfully into their engagement approaches.
Why pharmaceutical brands must act on digital trends now By Calum Griffin I've just witnessed the end of traditional pharmaceutical marketing. At this year's major oncology conference, I watched as TikTok usage surged 180% year-over-year, oncologists became viral content creators, and AI transformed from buzzword to business-critical tool. What struck me wasn't just the scale of change -…

Adobe Express has launched The AI Guide to explore how people across the UK are using AI in their everyday lives, both at home and at work. Key findings show that 40% of people use AI in both personal and professional settings, with 72% reporting a boost in productivity and 51% saving money.
·         Adobe Express has launched The AI Guide to explore how people across the UK are using AI in their everyday lives, both at home and at work. ·         Key findings show that 40% of people use AI in both personal and professional settings, with 72% reporting a boost in productivity and 51% saving money. ·         The guide was created to understand real-world AI habits, addres…

Fermentation development is the key to scaling bio-based innovation. Here we cover Isomerase’s step-by-step approach, from strain selection to downstream integration, helping biotech, pharma, and food tech companies accelerate reliable, scalable microbial production.
Microbial Fermentation Services: From Strain Design to Scalable Process Fermentation is one of the oldest biotechnologies, yet it’s now driving some of the most cutting-edge innovations in health, nutrition, and sustainability. From therapeutic enzymes and precision fermentation ingredients to biodegradable materials and alternative proteins, microbial fermentation has re-emerged as a core engine of the modern bioeconomy. However, while the science behind engineered microbes is advancing rapidly, the path from disc…

Artificial intelligence is transforming clinical research by helping predict trial outcomes more accurately, saving time, reducing costs and improving patient safety.
Artificial Intelligence (AI) is no longer just a buzzword it is transforming the way healthcare is delivered and its influence is now reaching deep into the world of clinical trials from predicting patient responses to helping researchers design better studies. AI is playing a growing role in how new drugs and therapies are tested with this shift the expectations from professionals in the research field are changing too, making it more important than ever to be trained with a strong foundation something a well designed clinical research course can now offer to future researchers and healthcare professionals. Clinical trials ar…

Understanding the basic systems crucial to cosmetic formulations is key for both novice and experienced cosmetic chemists.
In the rapidly evolving world of cosmetics, the quest for innovating sublime performing products starts with a solid foundation of formula design. Understanding the basic systems crucial to cosmetic formulations is key for both novice and experienced cosmetic chemists. These foundational systems ensure that the product not only meets consumer expectations but also adheres to safety and efficacy standards. Here, we delve into the seven essential systems that serve as the backbone for cosmetic formula design: Emulsification System, Efficacy System, Thickening System, Antioxidant System, Preservative System, Sensory Modification System, and Safety Assurance System. Emulsif…

Peer review is outdated and inefficient, risking bias and delays in science publishing. AI tools like DeSci Labs’ Referee Finder can streamline reviewer selection, expand expertise, and boost fairness and transparency in scientific assessment.
Peer review is the core quality control mechanism of science, determining what gets published and funded. Yet, the system is surprisingly outdated and inefficient. Editors face mounting pressure to find the right reviewers, but often rely on outdated tools or author-supplied information that can be biased. The result is a process that struggles with inefficiency, inconsistency and a lack of transparency, especially in how reviewers are chosen. Here, Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that p…

Federated Learning (FL) is transforming healthcare AI by allowing models to learn from data stored in different hospitals and devices without moving or sharing sensitive patient information. Unlike traditional centralized AI, FL keeps data private and secure, complying with strict regulations. Originally developed by Google, FL supports secure collaboration, fairness among small and large providers, and stable, personalized AI even with diverse or limited data. It also makes AI models more explainable and trustworthy for clinicians. Overall, FL turns privacy challenges into strengths, enabling hospitals to jointly build powerful, ethical, and inclusive AI models while protecting patient data.
Why Federated Learning is the Next Big Thing in Healthcare AI   The use of Artificia…

Read on to explore how we’re setting a new standard in peptide delivery. This initiative is strategically designed to accelerate the drug discovery journey for small-molecule-focused biotech companies by providing peptides with speed, precision, and reliability.
Timely access to high-quality peptides is essential in drug discovery, especially for screening, structure-activity relationship (SAR) studies, and early-stage preclinical research. Any delay in peptide synthesis can slow down critical experiments, affect project timelines, and limit the ability to make rapid decisions in lead optimisation. Recognising the critical role of fast, reliable, and risk-free peptide delivery in accelerating the development of new therapies, launched the o2h Peptide Guarantee Programme, designed to deliver…

The MD-42 License, issued by India’s Central Licensing Authority, is mandatory for manufacturing Class C and D medical devices like stents and implants. To obtain it, manufacturers must have ISO 13485-compliant facilities, qualified staff, and follow GMP. The application involves submitting detailed documentation via the CDSCO SUGAM portal, paying fees, and passing inspections. Valid for 5 years, the MD-42 License ensures regulatory compliance, builds trust, and enables market access. Expert assistance can simplify the process and help avoid delays or rejections.
What is an MD-42 License? An MD-42 license is granted by the Central Licensing Authority (CLA) to manufacturers of Class C and D medical devices. This license ensures your products meet strict safety, quality, and performance stand…